antibody level – Page 5 – Communicable Diseases Research

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Article

Published on 2021-11-112022-10-31
Journal: Cell [Category] COVID-19, MERS, SARS,

[키워드] Abstract accelerate accelerated accompanied acute respiratory syndrome addressed administration Alpha amplified antibody antibody level B cell B.1.1.7 BNT162b2 BNT162b2 mRNA vaccine BNT162b2 vaccine CD4 cellular circulating contribute coronavirus Coverage COVID-19 COVID-19 vaccine dose dosing interval effective expressing extended interval extension healthcare Humoral response IL-2 immunogenic immunogenicity individuals induce Infection introduced mRNA vaccine neutralization neutralizing antibody of BNT162b2 Protective protocol regimen response responses SARS-CoV-2 SARS-COV-2 infection second dose single dose sustained T cell the spike protein Trial United Kingdom Vaccine vaccine dose variant variants of concern
[DOI] 10.1016/j.cell.2021.10.011 PMC 바로가기 [Article Type] Article

Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins

근원이없는 COVID-19 긍정적 인 개체로부터의 항체의 교차 반응성, B.1.351, B.1.617.2 및 p.1 SARS-COV-2 스파이크 단백질

Article

Published on 2021-11-082022-09-01
Journal: Scientific Reports [Category] MERS, SARS, 변종, 진단, 치료기술,

[키워드] ACE-2 ACE-2 receptor Adults affinity analyzed antibodies antibody antibody level antibody levels B.1.351 B.1.617.1 B.1.617.2 Beta BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 collected COVID-19 cross-reactivity Delta ectodomain Effectiveness elicited enrolled Evidence evidence of except for Gamma humoral Humoral response implication individual individuals infected with SARS-CoV-2 inhibited Interaction interactions nCoV neutralization Optical sensors P.1 P.1 variant pandemic PCR-confirmed positive individual Proteins relative SARS-CoV-2 spike SARS-CoV-2 spike protein SARS-CoV-2 variant SARS-CoV-2 variants sera Spike protein Spike proteins SPR Spread sustained the spike protein vaccinated individual vaccinated individuals vaccination variant spike VoC VOCs
[DOI] 10.1038/s41598-021-00844-z PMC 바로가기 [Article Type] Article

Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age

Article

Published on 2021-11-042022-10-28
Journal: Vaccines [Category] COVID-19,

Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection

COVID-19의 항체 반응 패턴 프로파일링: SARS-CoV-2 감염의 진화에서 스파이크 S1-반응성 IgA 서명

Immunology

Published on 2021-11-032022-09-12
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단,

[키워드] acute respiratory syndrome antibody antibody level antibody production Antibody Response antigens baseline Characteristics Clinical course Clinical management clinical manifestations Clinical outcome Cohort coronavirus coronavirus disease COVID-19 COVID-19 patient detectable diagnosed driver dropped exhibiting First wave heterogeneous IgA IgG IgG level IgM Italy levels of antibodies long-lasting magnitude majority marker Neutralizing Neutralizing activity Neutralizing antibodies pandemic Patient pattern persistence Perspective predict Profiling reactive reflect response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 S1 severity signature spike statistical subsequent the antibody response the disease the SARS-CoV-2 Vaccination strategies VoC
[DOI] 10.3389/fimmu.2021.772239 PMC 바로가기 [Article Type] Immunology

Dynamics of IgG-avidity and antibody levels after Covid-19

Covid-19 이후의 IgG 결합력 및 항체 수준의 역학

Article

Published on 2021-11-012022-09-11
Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, 치료기술, 치료법,

Humoral Response to SARS-CoV-2 Vaccine of a Patient Receiving Methotrexate Treatment and Implications for the Need of Monitoring

Case Report

Published on 2021-10-092022-10-28
Journal: Vaccines [Category] COVID-19,

Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection

Research Article

Published on 2021-09-292022-10-30
Journal: Microbiology Spectrum [Category] COVID-19, MERS, SARS,

[키워드] addition antibody Antibody binding antibody level Antigen antigens approach B.1.1.7 B.1.351 B.1.351 variant Beta biosensor CoV2 COVID-19 COVID-19 infection Critical detection diagnostic effective Efficacy effort elevated ELISA enzyme-linked immunosorbent fluorescent Frame Human immune response increases in infected individuals Infection information multiple antigen multiplex novel nucleocapsid performed plasmonic Prevalence Protein quantification Quantitative Rapid resolved Result SARS CoV-2 sequence serological response significant decrease significantly Spike protein strain subject the antibody response the timing vaccination vaccination against COVID-19 Vaccine variant viral variant virus virus variant was used
[DOI] 10.1128/Spectrum.00890-21 PMC 바로가기 [Article Type] Research Article

Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel

코로나19 및 예방접종 후 면역: 의료진 대상 1년 이상 추적조사

Original Paper

Published on 2021-09-252022-09-12
Journal: Infection [Category] COVID19(2023년), SARS, 진단,

Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report

Article

Published on 2021-09-172022-10-28
Journal: Vaccines [Category] COVID-19,

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

초기 SARS-CoV-2 백신 접종 반응은 BNT162b2에 대한 추가 반응을 예측할 수 있지만 AZD1222에 대해서는 예측할 수 없습니다

Article

Published on 2021-09-012022-09-12
Journal: International Journal of Infectious Diseases [Category] SARS, 진단,